GoodRx Holdings Inc (GDRX) FinancialsGDRXGoodRx Holdings Inc

Evaluating the bottom line, GoodRx Holdings, Inc. maintains a gross margin of 78.41%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 12.21%, while the net margin is 4.26%. These profitability ratios, combined with a Return on Equity (ROE) of 2.52%, provide a clear picture of how effectively GDRX converts its operational activities into shareholder value.

In the context of the broader market, GDRX competes directly with industry leaders such as TDOC and USPH. With a market capitalization of $1.25B, it holds a leading position in the sector. When comparing efficiency, GDRX's gross margin of 78.41% stands against TDOC's 53.58% and USPH's 18.47%. Such benchmarking helps identify whether GoodRx Holdings, Inc. is trading at a premium or discount relative to its financial performance.

GoodRx has shown a slight decline in revenue for Q2 2026, reporting $200.41 million, down 1.3% year-over-year, but has raised its full-year revenue guidance to $790 million to $805 million, indicating potential for recovery.